Keri Kim

Dr. Keri Kim


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Optics and Lasers in Engineering
Verified
Journal Article
Closed access
HMHyowon Moon
Hyowon Moon
JJJinwoo Jeong
Jinwoo Jeong
SKSungchul Kang
Sungchul Kang
Keri KimKeri Kim
Keri Kim
YSYong-Won Song
Yong-Won Song
JKJinseok Kim
Jinseok Kim

18 March 2021 in IEEE/ASME Transactions on Mechatronics
Verified
Journal Article
Closed access
JKJeongryul Kim
Jeongryul Kim
SKSeong-Il Kwon
Seong-Il Kwon
YMYonghwan Moon
Yonghwan Moon
Keri KimKeri Kim
Keri Kim
Hyper-redundantmanipulators (HRMs) are widely used in minimally invasive surgery (MIS) because of their flexibility, dexterity, and compactness. However, when an external load acts on an HRM, its bending motion is disturbed and the workspace decreases. In addition, the external load increases the cable tension, and thin cables may break due to their low breaking strengths. This article proposes a cable-movable rolling joint that increases the workspace for MIS under an external load and reduces the actuating cable tension through cable movement. Furthermore, it presents an optimized motion estimation analysis method that verifies the manipulator performance by finding the equilibrium position and predicting the shape and tip position. The simulated manipulator exhibited a shape similar to that of the prototype and an average tip position difference of 4.59% based on the prototype length. Under an external load of 150 g, the workspace and cable tension of the prototype were 27.32% larger and 1.79 N lower than those of the conventional rolling joint, respectively. The new cable-movable mechanism and estimation analysis method will help improve the bending performance and position accuracy of HRMs for MIS.

8 May 2020 in Biomedical Optics Express
Verified
Journal Article
Closed access
GOGyungseok Oh
Gyungseok Oh
HCHong Jun Cho
Hong Jun Cho
SSSeung Beum Suh
Seung Beum Suh
YJYuhyun Ji
Yuhyun Ji
HCHak Suk Chung
Hak Suk Chung
Keri KimKeri Kim
Keri Kim
A multicolor fluorescence imaging device was recently developed for image-guided surgery. However, conventional systems are typically bulky and function with two cameras. To overcome these issues, we developed an economical home-built fluorescence imaging device based on a single RGB-IR sensor that can acquire both color and fluorescence images simultaneously. The technical feasibility of RGB-IR imaging was verified ex vivo in chicken breast tissue using fluorescein isothiocyanate (FITC), cyanine 5 (Cy5), and indocyanine green (ICG) as fluorescent agents. The minimum sensitivities for FITC, Cy5, and ICG were 0.200 µM, 0.130 µM, and 0.065 µM, respectively. In addition, we validated the fluorescence imaging of this device in vitro during a minimally invasive procedure using smURFP-labeled probiotics, which emit a spectrum similar to that of Cy5. Our preliminary study of the ex vivo tissue suggests that Cy5 and ICG are good candidates for deep tissue imaging. In addition, the tumor-specific amplification process was visualized using cancer cells incubated with probiotics that had been labeled with a fluorescent protein. Our approach indicates the potential for in vivo screening of tumors in rodent tumor models.

21 May 2025 in Advanced Materials
Verified
Journal Article
Open access
DLDohee Lee
Dohee Lee
HJHeung Jin Jeon
Heung Jin Jeon
DJDohyub Jang
Dohyub Jang
Deukhee LeeDeukhee Lee
Deukhee Lee
SKSolbi Kim
Solbi Kim
SSSeungBeum Suh
SeungBeum Suh
Current imaging techniques suffer from a lack of specificity and resolution, leading to inaccurate tumor imaging and limited applicability of targeted contrast agents, as they require cancer‐specific development. The need for enhanced contrast through improved tumor‐to‐background ratio (TBR) and the toxicity from repeated injections due to fading fluorescent signals further complicate the issue. Additionally, challenges in visualizing the entire 3D tumor with surface‐stained contrast agents highlight the demand for advanced imaging solutions for more precise surgical guidance. A novel approach is proposed utilizing Streptavidin Associated Salmonella (SAS) as a contrast agent for image‐guided surgeries. SAS selectively proliferates in cancerous tissues and secretes streptavidin upon induction, enabling the binding of subsequently injected biotin‐conjugated fluorescent dyes. This approach enhances tumor visualization with a TBR of up to 15.3, far surpassing conventional agents (TBR ∼ 2), while enabling prolonged 3‐day imaging, deep tumor penetration, and precise invasive margin delineation with a single contrast agent injection. Furthermore, biosafety evaluations confirmed efficient bacterial clearance, absence of systemic toxicity, and stable physiological responses, supporting its potential for safe clinical translation. This innovative method offers substantial improvements over existing fluorescent contrast agents and holds promise for both diagnostic and therapeutic applications in cancer surgery.

1 March 2021 in International Journal of Control, Automation, and Systems
Verified
Journal Article
Closed access
PDF file
DCDongeun Choi
Dongeun Choi
SKSun Ho Kim
Sun Ho Kim
WLWoosub Lee
Woosub Lee
SKSungchul Kang
Sungchul Kang
Keri KimKeri Kim
Keri Kim

13 June 2024 in International Journal of Precision Engineering and Manufacturing
Verified
Journal Article
Closed access
PDF file
SCSunwoong Choi
Sunwoong Choi
YMYonghwan Moon
Yonghwan Moon
JKJeongryul Kim
Jeongryul Kim
Keri KimKeri Kim
Keri Kim